Ontrak (Ontrak) ROCE % : -163.13% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Ontrak ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ontrak's annualized ROCE % for the quarter that ended in Dec. 2023 was -163.13%.

Ontrak ROCE % Historical Data

The historical data trend for Ontrak's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ontrak ROCE % Chart

Ontrak Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-547.24

-27.34

-30.26

-95.50

-129.21

Ontrak Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-167.32	-168.55	-125.65	-143.29	-163.13

Ontrak ROCE % Calculation

Ontrak's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-20.798	/	( ( (25.757 - 9.469)	+	(19.846 - 3.942) )	/ 2 )
	=	-20.798	/	( (16.288	+	15.904)	/ 2 )
	=	-20.798	/	16.096
	=	-129.21 %

Ontrak's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-20.812	/	( ( (20.768 - 11.156)	+	(19.846 - 3.942) )	/ 2 )
	=	-20.812	/	( ( 9.612	+	15.904 )	/ 2 )
	=	-20.812	/	12.758
	=	-163.13 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Ontrak (NAS:OTRK) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ontrak ROCE % Related Terms

Thank you for viewing the detailed overview of Ontrak's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ontrak (Ontrak) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ontrak Inc (NAS:OTRK) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

OTRKP.PFD:USA HY10:Germany HY10:Germany

Address

2200 Paseo Verde Parkway, Suite 280, Henderson, NV, USA, 89052

Website

https://www.ontrakhealth.com

Ontrak Inc is an AI and telehealth-enabled, virtualized outpatient healthcare treatment company. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The company's technology-enabled platform provides claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized treatment program.

Executives

Judith Feld	officer: Chief Medical Officer	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James M. Messina	director	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
Arik Hill	officer: Chief Information Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Robert Accordino	officer: Chief Medical Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Mary Louise Osborne	officer: Chief Customer Officer	2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James J Park	officer: Chief Accounting Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Jonathan E. Mayhew	officer: Chief Executive Officer	ONE CVS DRIVE, WOONSOCKET RI 02895
Terren S Peizer	director, 10 percent owner, officer: CEO	11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Robert I Newton	officer: General Counsel and Secretary	1940 E. MARIPOSA AVE, ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
Katherine B Quinn	director	US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Robert Rebak	director	2120 COLORADO BLVD., SUITE 230, SANTA MONICA CA 90404
Curtis Medeiros	officer: Chief Operating Officer	2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Brandon H Laverne	officer: Chief Financial Officer	1940 E. MARIPOSA AVE., ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
David E Smith	10 percent owner	888 LINDA FLORA DRIVE, LOS ANGELES CA 90049
Gustavo A Giraldo	director	2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404